Dice CEO: Energy, T...
Health Care: Health Services
Enzo Biochem Inc. (ENZ: NYSE)
$1.79 -0.03 | -1.65%
06/01/12 - 04:03 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 27,000 | 27,000 | 67,000 | 40,000 | 40,000 | 0 | 0 |
| Shares Bought | 27,000 | 27,000 | 67,000 | 40,000 | 40,000 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 17.59M | 16.70M | 18.10M | 18.10M | 19.41M | 19.41M | 19.41M |
| Shares Bought | 1.58M | 866,377 | 981,412 | 975,432 | 3.59M | 3.59M | 3.59M |
| Shares Sold | 505,887 | 2.18M | 2.19M | 2.19M | 3.33M | 3.33M | 3.33M |
Portfolios with ENZ
- Portfolio NameUser Type
- UserBarron's Insider Purchases ...
- ContributorStockerblog.com Gene Therap...
- Userkelvinenz Portfolio 1
- UserS-0022
- UserTraderSteveUK Portfolio 1
- UserRT_in_CA
- UserSo far, I'm beating the S&a...
- Userjwcarmack Portfolio 1
- Userrecentoutperform070824
- Usersfields Portfolio 1
Latest ENZ Headlines from TheStreet
- Thursday Earnings Live Blog 10.14.10 | 04:10 pm
- Investors May See Upside Down Under 09.16.10 | 08:09 am
- Enzo Biochem 1Q Loss Narrows On Revenue Boost 12.10.09 | 04:12 pm
- Enzo Biochem 4Q Loss Widens On Costs 10.14.09 | 06:10 pm
- Tuesday's Health Winners & Losers 10.16.07 | 04:10 pm
- Enzo Biochem Falls on Court Dismissal 09.07.07 | 02:09 pm
- Friday's Health Winners & Losers 09.07.07 | 02:09 pm
- Checking Up on Biotech 08.10.07 | 04:08 pm
- Monday's Health Winners & Losers 10.16.06 | 02:10 pm
- Enzo Biochem Loss Widens 10.16.06 | 11:10 am
Press Releases for ENZ
- Enzo Biochem Launch Of Test For Measuring Risk Of Colorectal Cancer Underscores Growing Role Of Molecular Diagnostics - Business Wire 04.10.12 | 08:04 am
- Enzo Biochem Presents New AmpiProbe™ Nucleic Acid Amplification Platform Details At ESCMID London Meeting - Business Wire 04.01.12 | 04:04 pm
- Enzo Biochem To Present At Needham Healthcare Conference - Business Wire 03.27.12 | 12:03 pm
- Enzo Biochem Announces Expanded Distribution Agreement With Japan’s Cosmo Bio - Business Wire 03.20.12 | 07:03 am
- Enzo Biochem’s Clinical Laboratory Applies For NY State Health Department Approval For First Assay Based On Its AmpiProbe™ Amplification Platform - Business Wire 03.13.12 | 07:03 am
- Enzo Biochem Reports Improved Second Quarter Results - Business Wire 03.12.12 | 04:03 pm
- Enzo Biochem To Present New AmpiProbe™ Nucleic Acid Amplification Platform At ESCMID London Meeting - Business Wire 03.08.12 | 08:03 am
- Enzo Biochem Schedules Teleconference To Discuss 2012 Second Quarter Results On March 13, 2012 At 8:30 AM E.T. - Business Wire 03.08.12 | 07:03 am
- Enzo Biochem Receives Approval For Novel Blood Based Test For Colorectal Cancer Risk - Business Wire 02.21.12 | 08:02 am
- Enzo Biochem To Present At 2012 Leerink Swann Global Healthcare Conference - Business Wire 02.10.12 | 12:02 pm
Partner Headlines for ENZ
- Investors Should Wait Out Quest & LabCorp - Seeking Alpha 02.16.12 | 09:02 am
- Enzo Biochem: Personalized Medicine Is More Than Targeted Therapeutics - Seeking Alpha 04.03.11 | 07:04 am
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
- Top 5 Percentage Gainers On NYSE (DV, CKH, ENZ, LAD, CMG) - Benzinga 07.23.10 | 03:07 pm
- MB FINANCL INC (MBFI) - Profit Tracks - Zacks 04.13.10 | 01:04 am
- UPDATE 2-Enzo wins round in Applera patent fight - Reuters 03.26.10 | 04:03 pm
